2.jpg

CannaNews from
Cannabis and Hemp Insider

Defined Research launches pioneering clinical trial to study effects of CBD formula on human sleep

Updated: Apr 19

The double-blind, placebo-controlled trial of Defined Research’s patent-pending formula is an industry-first study of the effects of CBD on human restorative sleep (the combination of REM and deep sleep)




Defined Research, Inc., a science-based wellness company, today announced the launch of a pioneering and rigorous clinical trial to determine the effects of its CBD-based formula on human sleep physiology.


The double-blind, placebo-controlled trial of Defined Research’s patent-pending formula is an industry-first study of the effects of CBD on human restorative sleep (the combination of REM and deep sleep). Trial participants consist of ~100 adults suffering from insomnia selected from across the United States. Objective and subjective sleep data will be collected via wearable technology and participant surveys, respectively. Importantly, the clinical trial has been approved by an Institutional Review Board (IRB), which ensures that human studies are governed in accordance with FDA regulations and can be published in peer-reviewed scientific journals.


“After three years of painstaking product development and preliminary trials, we are excited to be on the pathway to determine if our novel CBD-based sleep formula increases restorative sleep in humans,” said Paul Muchowski, PhD, Defined Research’s CEO & CSO.


“If our IRB-approved study replicates our preliminary clinical studies, it will be a huge win for consumers, because they’ll finally have access to a CBD product with clinically validated data that they can actually believe in. Our hope is to disrupt the cannabis industry by setting a higher standard for truth in efficacy, holding all manufacturers more accountable for their product claims.”


Completion of the trial and commercialization of Defined Research’s first CBD sleep product are targeted for Q3 of 2022.


Dr. Muchowski is available for in-person investor meetings and press interviews at the Benzinga Cannabis Conference (April 19-21, 2022) at the Fontainebleu Hotel in Miami Beach, Florida. Please email information@definedresearch.com for more information.


About Defined Research

Defined Research, Inc. is a science-based wellness company dedicated to the development and clinical validation of proprietary plant-based products targeted for the relief of major human ailments. We envision a world where consumers can make all healthcare decisions based on accurate, scientifically-proven product claims.


For more information go to www.definedresearch.com

Company Contact:

Defined Research, Inc.

Email information@definedresearch.com

Website www.definedresearch.com